---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-009486"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2022-07-11T23:59:59+00:00"
generated_at: "2026-06-24T17:34:04.544574+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Zomedica closes acquisition of Revo Squared for $6M cash plus warrants, earn-outs up to $4M

## Summary
- Completed acquisition of Revo Squared on July 1, 2022 for $6M base cash, subject to working capital adjustments.
- Issued 10-year warrant to Revo Squared for 10M common shares at $0.2201 per share.
- Earn-out payments up to $4M: $2M each when Revo net sales exceed $5M and $10M in any calendar year through 2027.
- Revo's MicroView digital cytology platform automates slide preparation; manufacturing moving to Roswell, GA facility.
- Company expects to launch MicroView to veterinary market in 2023.

## SEC filing metadata
- accession: 0001654954-22-009486
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2022-07-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 3.02, 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495422009486/0001654954-22-009486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495422009486/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-009486
- JSON: https://secwatch.observer/filing/0001654954-22-009486.json
- Plain text: https://secwatch.observer/filing/0001654954-22-009486.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.